1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Licensing Program Analysts (LPA) Diego Escobar and Ashley Boothe conducted an unannounced Case Management visit on 9/3/2020 at 10:30 AM to conduct a health and safety check visit. During the visit, LPA met with, Jade Parker, Administrator, and stated the purpose of the visit.
LPAs toured the facility kitchen with Jade. LPAs observed at least one week of non-perishable foods and two days of perishable foods. LPAs obtained copies of itemized list of foods deliver to the facility every week.
LPAs and Administrator toured the rooms of three residents (R1, R2, and R3) that receive home health services. LPA's reviewed the files of R1, R2 and R3. R1 is diagnosed with dementia and has a medical assessment dated 4/14/19. Administrator confirmed there was no updated medical assessment for R1.
LPAs observed R4 waiting for an ambulance to transport her to the hospital for wound care for a large, red, swollen tear discharging puss on the front of R4's right shin. LPA observed Jade look through R4's chart and question staff. R4 was released from the hospital on 8/23/2020 with physician's instructions to "have your facility check the wound daily" and to follow up with primary care provider within 1 to 3 days. Staff 1 (S1) confirmed no follow up was done with R4's primary care provider. The Activities Daily Living Flow sheet is signed by a caregiver from 8/23/2020 to 9/2/2020 "Skin Integrity check (note areas of concern on progress notes) has been signed off with no additional notes on the status of the wound. S1 stated that they have not been assisting in changing her bandage.
LPA's reviewed the facility's narcotic medication logs for memory care residents. Administrator stated, R5's narcotic medication, Alprazolam, was destroyed with S2 on 9/1/2020. LPAs asked for medication destruction records. Centrally stored medication and destruction record (CSMDR) was provided to LPAs. CSMDR is missing expiration date, date filled, date started, and name of pharmacy upon intake of the medication.
CONTINUES ON LIC 809-C |